Efficacy of β-hydroxy-β-methylbutyrate supplementation in elderly and clinical populations

Nutrition

Volumn 29, Issue 1, 2013, Pages 29-36

  Fitschen, Peter J ^a   Wilson, Gabriel J ^b   Wilson, Jacob M ^c   Wilund, Kenneth R ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b the State University of New Jersey   (United States)

^c UNIVERSITY OF TAMPA   (United States)

Author keywords

Hydroxy methylbutyrate B; Chronic disease; Exercise; Lean mass; Muscle; Wasting

Indexed keywords

BETA HYDROXY BETA METHYLBUTYRATE; BUTYRIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

AGING; BODY FAT DISTRIBUTION; CACHEXIA; CLINICAL EFFECTIVENESS; DIET SUPPLEMENTATION; ELDERLY CARE; EVIDENCE BASED MEDICINE; GRIP STRENGTH; HUMAN; LEAN BODY WEIGHT; MORTALITY; MUSCLE EXERCISE; MUSCLE MASS; MUSCLE STRENGTH; MUSCULAR DYSTROPHY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; THERAPY EFFECT; TREATMENT DURATION;

AGED; AGING; ANIMALS; ATHLETES; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; HUMANS; MODELS, BIOLOGICAL; MUSCLE STRENGTH; MUSCLE, SKELETAL; MUSCULAR ATROPHY; SAFETY; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; VALERATES;

EID: 84870810192     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.05.005     Document Type: Review

References (58)

1. Janssen I., Heymsfield S.B., Wang Z.M., Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol 2000, 89:81-88.
2. Grimby G., Saltin B. The ageing muscle. Clin Physiol 1983, 3:209-218.
3. Larsson L., Grimby G., Karlsson J. Muscle strength and speed of movement in relation to age and muscle morphology. J Appl Physiol 1979, 46:451-456.
4. Frontera W.R., Suh D., Krivickas L.S., Hughes V.A., Goldstein R., Roubenoff R. Skeletal muscle fiber quality in older men and women. Am J Physiol Cell Physiol 2000, 279:C611-C618.
5. Reid K.F., Naumova E.N., Carabello R.J., Phillips E.M., Fielding R.A. Lower extremity muscle mass predicts functional performance in mobility-limited elders. J Nutr Health Aging 2008, 12:493-498.
6. Landi F., Liperoti R., Fusco D., Mastropaolo S., Quattrociocchi D., Proia A., et al. Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc 2012, 13:121-126.
7. Zeiderman M.R., McMahon M.J. The role of objective measurement of skeletal muscle function in the pre-operative patient. Clin Nutr 1989, 8:161-166.
8. Andreyev H.J., Norman A.R., Oates J., Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?. Eur J Cancer 1998, 34:503-509.
9. Hoots W.K., Mahoney E., Donfield S., Bale J., Stehbens J., Maeder M., et al. Are there clinical and laboratory predictors of 5-year mortality in HIV-infected children and adolescents with hemophilia?. J Acquir Immune Defic Syndr 1998, 18:349-357.
10. Dodson S., Baracos V.E., Jatoi A., Evans W.J., Cella D., Dalton J.T., et al. Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med 2011, 62:265-279.
11. Van Kovering M., Nissen S.L. Oxidation of leucine and alpha-ketoisocapruate to beta-hydroxy beta-methylbutyrate in vivo. Am J Physiol Endocrinol Metab 1992, 262:27-31.
12. Wilson G.J., Wilson J.M., Manninen A.H. Effects of beta-hydroxy-beta-methylbutyrate (HMB) on exercise performance and body composition across varying levels of age, sex, and training experience: a review. Nutr Metab 2008, 5:1.
13. United States Department of Agriculture National nutrient database for standard reference [database on Internet] 2011, Beltsville, MD: United States Department of Agriculture, Available at:, Accessed December 1, 2011. http://www.ars.usda.gov.
14. Vukovich M.D., Slater G., Macchi M.B., Turner M.J., Fallon K., Boston T., et al. beta-hydroxy-beta-methylbutyrate (HMB) kinetics and the influence of glucose ingestion in humans. J Nutr Biochem 2001, 12:631-639.
15. Gallagher P.M., Carrithers J.A., Godard M.P., Schulze K.E., Trappe S.W. Beta-hydroxy-beta-methylbutyrate ingestion, part I: effects on strength and fat free mass. Med Sci Sports Exerc 2000, 32:2109-2115.
16. Nissen S., Sharp R., Ray M., Rathmacher J.A., Rice D., Fuller J.C., et al. Effect of leucine metabolite beta-hydroxy-beta-methylbutyrate on muscle metabolism during resistance-exercise training. J Appl Physiol 1996, 81:2095-2104.
17. Nissen S.L., Abumrad N.N. Nutritional role of the leucine metabolite B-hydroxy B-methylbutyrate (HMB). J Nutr Biochem 1997, 8:300-311.
18. Gallagher P.M., Carrithers J.A., Godard M.P., Schulze K.E., Trappe S.W. Beta-hydroxy-beta-methylbutyrate ingestion, part II: effects on hematology, hepatic and renal function. Med Sci Sports Exerc 2000, 32:2116-2119.
19. Nissen S., Sharp R.L., Panton L., Vukovich M., Trappe S., Fuller J.C. Beta-hydroxy-beta-methylbutyrate (HMB) supplementation in humans is safe and may decrease cardiovascular risk factors. J Nutr 2000, 130:1937-1945.
20. Rathmacher J.A., Nissen S., Panton L., Clark R.H., Eubanks May P., Barber A.E., et al. Supplementation with a combination of beta-hydroxy-beta-methylbutyrate (HMB), arginine, and glutamine is safe and could improve hematological parameters. JPEN J Parenter Enteral Nutr 2004, 28:65-75.
21. May P.E., Barber A., D'Olimpio J.T., Hourihane A., Abumrad N.N. Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine. Am J Surg 2002, 183:471-479.
22. Clark R.H., Feleke G., Din M., Yasmin T., Singh G., Khan F.A., et al. Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study. JPEN J Parenter Enteral Nutr 2000, 24:133-139.
23. Baier S., Johannsen D., Abumrad N., Rathmacher J.A., Nissen S., Flakoll P. Year-long changes in protein metabolism in elderly men and women supplemented with a nutrition cocktail of beta-hydroxy-beta-methylbutyrate (HMB), L-arginine, and L-lysine. JPEN J Parenter Enteral Nutr 2009, 33:71-82.
24. Nissen S.L., Sharp R.L. Effect of dietary supplements on lean mass and strength gains with resistance exercise: a meta-analysis. J Appl Physiol 2003, 94:651-659.
25. Rowlands D.S., Thomson J.S. Effects of beta-hydroxy-beta-methylbutyrate supplementation during resistance training on strength, body composition, and muscle damage in trained and untrained young men: a meta-analysis. J Strength Cond Res 2009, 23:836-846.
26. Hsieh L.C., Chow C.J., Chang W.C., Liu T.H., Chang C.K. Effect of beta-hydroxy-beta-methylbutyrate on protein metabolism in bed-ridden elderly receiving tube feeding. Asia Pac J Clin Nutr 2010, 19:200-208.
27. Vukovich M.D., Stubbs N.B., Bohlken R.M. Body composition in 70-year-old adults responds to dietary beta-hydroxy-beta-methylbutyrate similarly to that of young adults. J Nutr 2001, 131:2049-2052.
28. Flakoll P., Sharp R., Baier S., Levenhagen D., Carr C., Nissen S. Effect of beta-hydroxy-beta-methylbutyrate, arginine, and lysine supplementation on strength, functionality, body composition, and protein metabolism in elderly women. Nutrition 2004, 20:445-451.
29. Fuller J.C., Baier S., Flakoll P., Nissen S.L., Abumrad N.N., Rathmacher J.A. Vitamin D status affects strength gains in older adults supplemented with a combination of {beta}-hydroxy-{beta}-methylbutyrate, arginine, and lysine: a cohort study. JPEN J Parenter Enteral Nutr 2011, 35:757-762.
30. Wilson J.M., Grant S.C., Lee S.R., Masad I.S., Park Y.M., Henning P.C., et al. Beta-hydroxy-beta-methyl-butyrate blunts negative age-related changes in body composition and functionality and myofiber dimensions in rats. J Int Soc Sports Nutr 2012, 9:18.
31. Cabe P.A., Tilson H.A., Mitchell C.L., Dennis R. A simple recording grip strength device. Pharmacol Biochem Behav 1978, 8:101-102.
32. Klein S., Kinney J., Jeejeebhoy K., Alpers D., Hellerstein M., Murray M., et al. Nutrition support in clinical practice: review of published data and recommendations for future research directions. Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. Am J Clin Nutr 1997, 66:683-706.
33. Kuhls D.A., Rathmacher J.A., Musngi M.D., Frisch D.A., Nielson J., Barber A., et al. Beta-hydroxy-beta-methylbutyrate supplementation in critically ill trauma patients. J Trauma 2007, 62:125-131.
34. Hsieh L.C., Chien S.L., Huang M.S., Tseng H.F., Chang C.K. Anti-inflammatory and anticatabolic effects of short-term beta-hydroxy-beta-methylbutyrate supplementation on chronic obstructive pulmonary disease patients in intensive care unit. Asia Pac J Clin Nutr 2006, 15:544-550.
35. Marcora S., Lemmey A., Maddison P. Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial. Clin Nutr 2005, 24:442-454.
36. Clements R.H., Saraf N., Kakade M., Yellumahanthi K., White M., Hackett J.A. Nutritional effect of oral supplement enriched in beta-hydroxy-beta-methylbutyrate, glutamine and arginine on resting metabolic rate after laparoscopic gastric bypass. Surg Endosc 2011, 25:1376-1382.
37. Smith H.J., Mukerji P., Tisdale M.J. Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss. Cancer Res 2005, 65:277-283.
38. Nunes E.A., Kuczera D., Brito G.A., Bonatto S.J., Yamazaki R.K., Tanhoffer R.A., et al. Beta-hydroxy-beta-methylbutyrate supplementation reduces tumor growth and tumor cell proliferation ex vivo and prevents cachexia in Walker 256 tumor-bearing rats by modifying nuclear factor-kappaB expression. Nutr Res 2008, 28:487-493.
39. Aversa Z., Bonetto A., Costelli P., Minero V.G., Penna F., Baccino F.M., et al. beta-hydroxy-beta-methylbutyrate (HMB) attenuates muscle and body weight loss in experimental cancer cachexia. International journal of oncology 2011, 38:713-720. Epub 2010/12/25.
40. Caperuto E.C., Tomatieli R.V., Colquhoun A., Seelaender M.C., Costa Rosa L.F. Beta-hydroxy-beta-methylbutyrate supplementation affects Walker 256 tumor-bearing rats in a time-dependent manner. Clin Nutr 2007, 26:117-122.
41. Wu G., Bazer F.W., Davis T.A., Kim S.W., Li P., Marc Rhoads J., et al. Arginine metabolism and nutrition in growth, health and disease. Amino Acids 2009, 37:153-168.
42. Vermeulen M.A., van de Poll M.C., Ligthart-Melis G.C., Dejong C.H., van den Tol M.P., Boelens P.G., et al. Specific amino acids in the critically ill patient-exogenous glutamine/arginine: a common denominator?. Crit Care Med 2007, 35(9 suppl):S568-S576.
43. Hao Y., Jackson J.R., Wang Y., Edens N., Pereira S.L., Alway S.E. Beta-hydroxy-beta-methylbutyrate reduces myonuclear apoptosis during recovery from hind limb suspension-induced muscle fiber atrophy in aged rats. Am J Physiol Regul Integr Comp Physiol 2011, 301:R701-R715.
44. Kovarik M., Muthny T., Sispera L., Holecek M. Effects of beta-hydroxy-beta-methylbutyrate treatment in different types of skeletal muscle of intact and septic rats. J Physiol Biochem 2010, 66:311-319.
45. Payne E.T., Yasuda N., Bourgeois J.M., Devries M.C., Rodriguez M.C., Yousuf J., et al. Nutritional therapy improves function and complements corticosteroid intervention in mdx mice. Muscle Nerve 2006, 33:66-77.
46. Eley H.L., Russell S.T., Baxter J.H., Mukerji P., Tisdale M.J. Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli. Am J Physiol Endocrinol Metab 2007, 293:E923-E931.
47. Holecek M., Muthny T., Kovarik M., Sispera L. Effect of beta-hydroxy-beta-methylbutyrate (HMB) on protein metabolism in whole body and in selected tissues. Food Chem Toxicol 2009, 47:255-259.
48. Ostaszewski P., Kostiuk S., Balasinska B., Jank M., Papet I., Glomot F. The leucine metabolite 3-hydroxy-3-methylbutyrate (HMB) modifies protein turnover in muscles of laboratory rats and domestic chickens in vitro. J Anim Physiol Anim Nutr 2000, 84:1-8.
49. Kornasio R., Riederer I., Butler-Browne G., Mouly V., Uni Z., Halevy O. Beta-hydroxy-beta-methylbutyrate (HMB) stimulates myogenic cell proliferation, differentiation and survival via the MAPK/ERK and PI3K/Akt pathways. Biochim Biophys Acta 2009, 1793:755-763.
50. Schwartz A.L., Ciechanover A. The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu Rev Med 1999, 50:57-74.
51. Smith H.J., Wyke S.M., Tisdale M.J. Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by beta-hydroxy-beta-methylbutyrate. Cancer Res 2004, 64:8731-8735.
52. Kandarian S.C., Jackman R.W. Intracellular signaling during skeletal muscle atrophy. Muscle Nerve 2006, 33:155-165.
53. Eley H.L., Russell S.T., Tisdale M.J. Mechanism of attenuation of muscle protein degradation induced by tumor necrosis factor-alpha and angiotensin II by beta-hydroxy-beta-methylbutyrate. Am J Physiol Endocrinol Metab 2008, 295:E1417-E1426.
54. Shi X., Garry D.J. Muscle stem cells in development, regeneration, and disease. Genes Dev 2006, 20:1692-1708.
55. Verdijk L.B., Koopman R., Schaart G., Meijer K., Savelberg H.H., van Loon L.J. Satellite cell content is specifically reduced in type II skeletal muscle fibers in the elderly. Am J Physiol Endocrinol Metab 2007, 292:E151-E157.
56. Lenk K., Schuler G., Adams V. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle 2010, 1:9-21.
57. Melstrom L.G., Melstrom K.A., Ding X.Z., Adrian T.E. Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia. Histol Histopathol 2007, 22:805-814.
58. Nunes E.A., Lomax A.R., Noakes P.S., Miles E.A., Fernandes L.C., Calder P.C. Beta-hydroxy-beta-methylbutyrate modifies human peripheral blood mononuclear cell proliferation and cytokine production in vitro. Nutrition 2011, 27:92-99.